AXIOM Innovations – Issue 21, November 2016
Today´s demographics demand approaches to therapy that are “as individual as your patients”. ARTIS pheno®1, the new robotic system, offers expanded potential in interventional radiology and surgery.
And with obesity on the rise, we report on a promising trial at Johns Hopkins where physicians rely on Artis zeego® for bariatric arterial embolization to treat obese patients.
More can be seen in “One Room, One System, All Applications”: Read how multiple disciplines successfully share an Artis zee with PURE® at the Klinikum Ingolstadt.
Find a range of interesting articles focusing on low-dose and high-quality imaging capabilities, and delivering best practice examples from the world of interventional radiology.
ARTIS pheno is pending 510(k) clearance, and is not yet commercially available in the United States or in other countries.